Drug Profile
ARH 047108
Alternative Names: RAPIDLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastrointestinal disorders
Most Recent Events
- 25 Jul 2002 Discontinued - Phase-II for Gastrointestinal disorders in Europe (unspecified route)
- 20 Dec 2000 Phase-II clinical trials for Gastrointestinal disorders in Europe (Unknown route)
- 07 Feb 2000 New profile